Login / Signup

Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.

Melissa R KaufmanHoward B GoldmanChristopher J ChermanskyCharles W ButrickMichael J KennellyKenneth M PetersLieschen H QuirozJason B BennettSherry ThomasCharles G MarguetKevin D BensonUna J LeeEric R SokolChristopher E WolterDaniel M KatzChristopher M TarnayDanielle AntoshMichael H HeitChristian RehmeMickey KarramScott SnyderEmanuele CanestrariRon J JankowskiMichael B Chancellor
Published in: Neurourology and urodynamics (2024)
ClinicalTrials.gov identifier: NCT01893138; EudraCT number: 2014-002919-41.
Keyphrases
  • double blind
  • cell therapy
  • placebo controlled
  • single cell
  • open label
  • bone marrow
  • clinical trial
  • randomized controlled trial
  • phase ii
  • stem cells